Raras
Buscar doenças, sintomas, genes...
Síndrome de paraparesia espástica-cataratas-perturbação da linguagem
ORPHA:615938CID-10 · E71.3OMIM 619338DOENÇA RARA
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Esta é uma lista de códigos de doenças no banco de dados Online Mendelian Inheritance in Man (OMIM). Estas são doenças que podem ser herdadas por meio de um mecanismo genético mendeliano. OMIM é um dos bancos de dados abrigados no Centro Nacional de Informações sobre Biotecnologia dos EUA.

🏥
SUS: Cobertura mínimaScore: 15%
CID-10: E71.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (7)
0202010279
Dosagem de aminoácidos (erros inatos)metabolic_test
0202010295
Dosagem de ácidos orgânicos na urinagenetic_test
0202010490
Teste de triagem para erros inatos do metabolismonewborn_screening
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202080013
Teste do pezinho (triagem neonatal)nutritional
0301070040
Atendimento em reabilitação — doenças raras
+1 outros procedimentos
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
8 sintomas
🫃
Digestivo
1 sintomas
👁️
Olhos
1 sintomas

+ 5 sintomas em outras categorias

Características mais comuns

100%prev.
Habilidade atrasada de andar
Frequência: 12/12
100%prev.
Catarata
Frequência: 12/12
100%prev.
Paraparesia espástica
Frequência: 12/12
100%prev.
Início na infância
Frequência: 12/12
83%prev.
Atraso no desenvolvimento da fala e da linguagem
Frequência: 10/12
50%prev.
Hipotonia axial
Frequência: 6/12
15sintomas
Muito frequente (5)
Frequente (3)
Ocasional (6)
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 15 características clínicas mais associadas, ordenadas por frequência.

Habilidade atrasada de andarDelayed ability to walk
Frequência: 12/12100%
CatarataCataract
Frequência: 12/12100%
Paraparesia espásticaSpastic paraparesis
Frequência: 12/12100%
Início na infânciaInfantile onset
Frequência: 12/12100%
Atraso no desenvolvimento da fala e da linguagemDelayed speech and language development
Frequência: 10/1283%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico202245 papers
Linha do tempo
2026Hoje · 2026📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição.

Autosomal dominant
FAR1Fatty acyl-CoA reductase 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the reduction of saturated and unsaturated C16 or C18 fatty acyl-CoA to fatty alcohols (PubMed:15220348, PubMed:24108123, PubMed:35238077). It plays an essential role in the production of ether lipids/plasmalogens which synthesis requires fatty alcohols (PubMed:20071337, PubMed:24108123, PubMed:33239752). In parallel, it is also required for wax monoesters production since fatty alcohols also constitute a substrate for their synthesis (By similarity) (PubMed:24108123, PubMed:35238077)

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (1)
Wax biosynthesis
MECANISMO DE DOENÇA

Peroxisomal fatty acyl-CoA reductase 1 disorder

An autosomal recessive metabolic disorder clinically characterized by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
60.3 TPM
Esôfago - Mucosa
59.2 TPM
Nervo tibial
58.9 TPM
Vagina
49.5 TPM
Útero
47.1 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
spastic paraparesis-cataracts-speech delay syndromefatty acyl-CoA reductase 1 deficiency
HGNC:26222UniProt:Q8WVX9

Variantes genéticas (ClinVar)

41 variantes patogênicas registradas no ClinVar.

🧬 FAR1: NM_032228.6(FAR1):c.234_235del (p.Lys78fs) ()
🧬 FAR1: NM_032228.6(FAR1):c.1479G>T (p.Trp493Cys) ()
🧬 FAR1: NM_032228.6(FAR1):c.1397T>C (p.Ile466Thr) ()
🧬 FAR1: NM_032228.6(FAR1):c.956-3C>T ()
🧬 FAR1: NM_032228.6(FAR1):c.1498T>C (p.Cys500Arg) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

1 via biológica associada aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de paraparesia espástica-cataratas-perturbação da linguagem

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
0 papers (10 anos)
#1

Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p.Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome).

Clinical genetics2026 Mar 20

Biallelic loss-of-function variants in FBXO31 cause autosomal-recessive intellectual disability. A recurrent de novo variant, c.1000G>A(p.Asp334Asn), has been described in association with an autosomal-dominant phenotype. To refine this phenotype and its clinical implications, we re-evaluated three published cases and ascertained four additional probands via advocacy networks, GeneMatcher, and clinician referral. Phenotyping included neurologic, behavioral, and dysmorphology assessment. All seven individuals carried the recurrent de novo FBXO31 p.Asp334Asn variant. A core neurodevelopmental profile was observed and included cerebral palsy (mixed hypotonia, spasticity, and dystonia), global developmental delay/intellectual disability, and speech impairment. Neuropsychiatric features were sometimes prominent and included attention-deficit/hyperactivity disorder, anxiety, stereotypies, autistic features, and behavioral dysregulation. Neuroimaging often showed a hypoplastic corpus callosum and posterior-predominant white-matter changes. In one individual, gray matter heterotopias were also observed. A subtle but consistent facial gestalt was noted. Recurrent FBXO31 p.Asp334Asn variants lead to a recognizable neurodevelopmental syndrome. Based on our findings, we recommend including FBXO31 in diagnostic algorithms for cerebral palsy and neurodevelopmental disorders. We propose the descriptive term "autosomal dominant FBXO31-associated neurodevelopmental disorder," and-consistent with the validating laboratory and with support from the FBXO31 Foundation-propose the eponym "Kruer syndrome."

#2

CTNNB1-related disorders: clinical and radiological contributions from a French cohort.

Frontiers in neurology2026

CTNNB1 monoallelic pathogenic variants account for up to 4% of genetically determined cerebral palsy cases, yet their phenotypic spectrum remains poorly defined. We retrospectively analyzed 25 individuals with pathogenic CTNNB1 variants using medical records and a questionnaire. Data included genetic variants, perinatal history, developmental milestones, behavioral characteristics, head growth, feeding, sleep difficulties, neurological and ophthalmological assessments. Brain MRIs were reviewed by expert neuroradiologists. Twenty-two distinct heterozygous variants were identified. Microcephaly occurred in 16/22 patients. All exhibited global developmental delay, independent walking was achieved at a mean age of 2.1 years, with regression in 4/16 independent walkers. Behavioral disorders were frequent, as were oral sensorimotor disorders (21/25) and sleep disturbances (13/21). Lower limb hypertonia was present in 22/25 patients [spastic (8) and/or dystonic (11)]. Unstable gait were common among ambulatory patients. Exaggerated startle reactions, often since birth, were reported in 16/21. Exudative vitreoretinopathy was identified in 3/5 patients with retinal angiography. Brain MRI (19 patients) showed: thickening of anterior commissure (8), frontal lobe hypoplasia (9), widening of superior vermian sulci (10) and corpus callosum anomalies (7). This study broadens the spectrum of CTNNB1-related syndrome, reporting a complex motor phenotype combining (i) gait disturbances related to dystonic or non-dystonic hypertonia and unsteadiness, sometimes associated to dystonia in other body parts (ii) possible deterioration of motor achievements over the course of the disease (iii) an exaggerated startle reflex. New non-specific brain anomalies are precisely described. Our work underscores the need for registries and longitudinal studies to refine characterization and guide future therapies. PTS-related tetrahydrobiopterin deficiency (PTPSD) results in a lack of tetrahydropterin, an important cofactor for phenylalanine hydroxylase (PAH), tyrosine hydroxylase, and tryptophan hydroxylase. Deficiency can thus lead to neurotransmitter and neuropsychiatric disorders. The clinical spectrum of PTPSD is broad and differs according to age of onset, severity of disease, and whether preventative therapies were initiated and maintained from an early age. In the severe form, clinical symptoms may become apparent in the neonatal period and can include hypotonia, movement disorders, abnormal eye movements, autonomic dysregulation, and impaired development. Without treatment, developmental delays become more marked. Neurologic symptoms (dysarthria, dystonia, tremors, abnormal gait, parkinsonism, oculogyric crises, motor tics) may be ameliorated by treatment with sapropterin dihydrochloride and neurotransmitter precursors. Other features of the condition can include psychiatric comorbidities (ADHD, anxiety, depression), infant feeding difficulties leading to early growth failure, hyperprolactinemia, growth hormone deficiency, sleep issues, and autonomic dysfunction; many of these features can be ameliorated by appropriate treatment. In treated individuals, development often improves during adolescence, with many adults having a normal IQ level. In the mild (peripheral) form, affected individuals are usually asymptomatic apart from an increase in phenylalanine (Phe) levels. Some remain asymptomatic. However, with time, some have mild developmental delays and can develop deficiency of neurotransmitter production, such that treatment of some asymptomatic individuals may be required. The biochemical diagnosis of PTPSD is established in a proband with confirmed hyperphenylalaninemia, elevated neopterin levels, reduced biopterin levels, and a decreased biopterin-to-neopterin ratio in urine or dried blood spots (DBS) and normal dihydropteridine reductase (DHPR) activity in DBS. The molecular diagnosis of PTPSD is established in a proband by identification of biallelic pathogenic (or likely pathogenic) variants in PTS by molecular genetic testing. Targeted therapies: Immediate therapy with sapropterin (tetrahydrobiopterin dihydrochloride; BH4), a cofactor/cosubstrate of PAH, is recommended to reduce blood Phe concentrations in individuals with hyperphenylalaninemia. If sapropterin is not available, dietary Phe restriction should be implemented. Because sapropterin has limited access to the central nervous system (CNS), or rather, this access is only achieved at high doses, therapy with sapropterin does not normalize the activity of tyrosine or tryptophan hydroxylase in people with PTPSD. Additional treatment strategies are necessary for long-term management and may include the use of neurotransmitter precursors (levodopa plus decarboxylase inhibitor (DCI), i.e., carbidopa or benserazide), 5-hydroxytryptophan, and/or dopamine (rotigotine patch, pramipexole) and/or serotonin agonists, or other medications (MAO inhibitors such as selegiline) to address specific neurotransmitter deficiencies and maintain optimal neurologic function. Supportive care: Optimization of dosage and intervals of levodopa/DCI in those with abnormal movements/parkinsonism; growth hormone supplementation and/or optimization of neurotransmitter precursor therapy for growth hormone deficiency; optimization of neurotransmitter precursor therapy for recurrent hyperthermia; anticholinergic treatment may be considered for hypersalivation; standard treatment for developmental delay, spasticity, epilepsy, sleep disorders, and decreased bone mineral density. Biochemical surveillance: Routine Phe monitoring in infants (age <1 year) weekly until normalized and then every three to six months once levels normalize; every six months in children younger than age 12 years; and every six to 12 months in adolescents and adults; the Phe target ranges correspond to those of PAH deficiency. Prolactin level at each visit. Routine clinical visits with a metabolic specialist (and metabolic dietician if on Phe-restricted diet) every one to three months in infants (age <1 year), every three to six months between ages one and seven years, and every six to 12 months in those age eight years and older. General surveillance: At each visit, measure growth parameters and evaluate nutritional status; asses for new neurologic manifestations (changes in tone, seizures, movement disorders); monitor developmental progress and assess educational needs; monitor for behavioral issues (anxiety, ADHD, emotional dysregulation, depression, aggression); and assess for signs and symptoms of sleep disorders. At ages two, six, 12, and 18 years, consider neuropsychological evaluation. In adulthood, periodic parathormone levels and DXA scan. As needed, consider EEG to differentiate from movement disorder seizures. Agents/circumstances to avoid: Persons with PTPSD on Phe-reduced diet should either avoid products containing aspartame or calculate total intake of Phe when using such products and adapt diet components accordingly. Evaluation of relatives at risk: If prenatal genetic testing has not been performed, each at-risk newborn sib should be evaluated immediately (at or just after 24 hours) after birth for PTPSD using measurement of blood Phe concentration to allow for earliest possible diagnosis and treatment. If older sibs have not undergone NBS or genetic testing for the known familial pathogenic variants in PTS, measure blood Phe concentrations to clarify their disease status. Pregnancy management: Women with PTPSD who have received appropriate treatment throughout childhood and adolescence and during pregnancy may have offspring with normal intellectual and behavioral development, particularly if levels of Phe are kept in the normal range during pregnancy. Intensive clinical and biochemical supervision by a multidisciplinary team before, during, and after pregnancy in a woman with PTPSD is essential to control the symptoms of the disease, adjust the treatment if needed, and monitor the development of the fetus. If the affected woman has elevated blood Phe concentrations during pregnancy, the fetus is at high risk for maternal phenylketonuria (MPKU) syndrome (reported specifically in women who have PAH deficiency as the primary cause of their elevated Phe levels), including malformations and intellectual disability, since Phe is a potent teratogen. PTPSD is inherited in an autosomal recessive manner. If both parents are known to be heterozygous for a PTS pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of inheriting neither of the familial PTS pathogenic variants. Children born of one parent with PTPSD and one parent with two normal PTS alleles are obligate heterozygotes. If the mother is the affected parent, MPKU syndrome is a critical issue. Females with PTPSD should receive counseling regarding the teratogenic effects of elevated maternal plasma Phe concentration (i.e., MPKU syndrome) when they reach childbearing age. Once the PTS pathogenic variants have been identified in an affected family member, carrier testing for at-risk relatives and prenatal/preimplantation genetic testing for PTPSD are possible.

#3

Systematic analysis of homozygous autosomal copy number losses in exomes improves diagnostic yield and uncovers ultra-rare recessive disorders.

medRxiv : the preprint server for health sciences2026 Jan 27

Systematic analysis of copy number variants (CNVs) in large datasets is challenging and there are limited studies of homozygous copy number losses in rare disease exome datasets. Here we leveraged the genomic uniqueness and relative under-representation of the Indian population in the current public genomic databases and identified 42,386 possible homozygous losses (median count 20 per individual, range 0 - 55; median size 2.95 kb, range 99 bp - 4.76 Mb) in a heterogeneous cohort of 2,021 individuals with suspected Mendelian disorders, who had undergone exome sequencing using 12 different capture kits in a resource-limited setting. Employing a genomic position loss-count based approach, we filtered 1,224 rare homozygous loss calls in 718 individuals (median count 1 per individual, range 0 - 22; median size 3.49 kb, range 121 bp - 4.76 Mb) for further analysis, thus significantly reducing the analysis burden. Clinical correlation and validation of these rare calls enabled 10 new diagnoses in 240 unsolved individuals with at least one filtered rare homozygous loss call. This, led to nearly two-fold increase in diagnosis owing to homozygous deletions in our cohort. Further analysis of the data and identification of additional affected individuals through collaboration led to identification of biallelic FILIP1 and FAM177A1 variants as causes of a syndromic arthrogryposis and a neuromuscular disorder respectively. Both these conditions have been recently proven as ultra-rare recessive disorders, thus validating our approach. We also show that biallelic loss-of-function TFCP2L1 variants cause chronic kidney disease and VPS36 variants cause a severe recessive neurodevelopmental disorder characterised by microcephaly, motor delay, agenesis of the corpus callosum, cerebellar atrophy, seizures, hypotonia, spasticity and early death. Overall, these results demonstrate a scalable approach to screen homozygous losses for improving diagnostic yield and discovering disease-genes in large exome cohorts.

#4

Expanding the neurological spectrum of HTLV-1 beyond HAM/TSP: a contemporary perspective.

Lancet regional health. Americas2026 Mar

Human T-lymphotropic virus type 1 (HTLV-1) has long been linked mainly to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). However, four decades of research show that the virus causes a much broader range of neurological conditions. In Latin America and the Caribbean-regions with high prevalence but limited awareness, diagnostic capacity, and treatment-its burden is especially severe. Misdiagnosis or neglect often delays care, leading to increased disability and emotional distress. This Personal View highlights the expanding neurological spectrum of HTLV-1, which includes rare but well-documented encephalopathy, cognitive decline, peripheral neuropathy, inflammatory myopathy, cerebellar dysfunction, autonomic disorders, motor neuron disease-like syndromes, and seizures. These can happen independently or alongside HAM/TSP. The proposed concept of an "HTLV-1 neurological complex" better represents this multifaceted involvement. Recognising this diversity is essential for accurate diagnosis and better outcomes, particularly in endemic settings. A paradigm shift is needed-one that broadens the clinical focus beyond myelopathy to encompass the full neurological spectrum, thereby improving global care and management.

#5

Identifying the Fourth Patient With Spastic Paraplegia 90, Extending the Phenotype Spectrum.

Clinical genetics2026 Jan

Spastic paraplegia 90 (SPG90; OMIM #620416, 620417) is a rare neurologic disease caused by monoallelic or biallelic variants in the serine palmitoyltransferase small subunit A (SPTSSA) gene. This syndrome is characterized by neurodevelopmental delay, sensorineural hearing loss, progressive motor impairment, and lower extremity spasticity. To date, only three patients have been reported. In this report, we present a 10-year-old female patient with global developmental delay, inability to walk, axial hypotonia, extremity spasticity, dystonia, distal renal tubular acidosis, recurrent urinary tract infections, nephrolithiasis, neurogenic bladder, and primary polydipsia. Exome sequencing revealed a heterozygous pathogenic variant (p.Thr51Ile), which was detected in two of the reported patients, suggesting a recurrent variant in this syndrome. The neurogenic bladder and primary polydipsia found in our patient are novel findings, and we propose that genitourinary problems may be a component of the syndrome.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p.Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome).

Clinical genetics
2026

CTNNB1-related disorders: clinical and radiological contributions from a French cohort.

Frontiers in neurology
2026

Expanding the clinical and immunological phenotypes of COPB1 deficiency.

Frontiers in immunology
2025

Expanding the Clinical Spectrum of RERE-Related Disorders: A Case Report of Neurodevelopmental Disorder with Brain Malformations Including Chiari Type I.

Molecular syndromology
2026

Systematic analysis of homozygous autosomal copy number losses in exomes improves diagnostic yield and uncovers ultra-rare recessive disorders.

medRxiv : the preprint server for health sciences
2025

Coffin-Lowry syndrome: a systematic review of RPS6KA3 confirmed cases and implications for diagnosis and counseling.

Frontiers in genetics
2026

Multiple Mitochondrial Dysfunction Syndrome Caused by IBA57 Gene Mutation: A Case Report and Literature Review.

Molecular genetics &amp; genomic medicine
2026

Expanding the neurological spectrum of HTLV-1 beyond HAM/TSP: a contemporary perspective.

Lancet regional health. Americas
2026

Biallelic TTBK1 variant causes a severe syndromic neurodevelopmental disorder: clinical and genetic insights from two siblings.

Journal of medical genetics
2026

The Age of Definitive Fusion Surgery for Early Onset Scoliosis Has Remained Constant Over the Past 2 Decades.

Journal of pediatric orthopedics
2025

Webb-Dattani syndrome in a 17-year-old girl.

Endocrinology, diabetes &amp; metabolism case reports
2025

Leukoencephalopathy, brain calcifications, and cysts (LCC): Two unique cases.

Rare (Amsterdam, Netherlands)
2025

Biallelic variants in TNR cause neurodevelopmental disorders with variable expressivity.

Journal of human genetics
2025

Two Chinese patients with Basilicata-Akhtar syndrome caused by novel MSL3 variants: a case report and literature review.

Translational pediatrics
2025

USP18 gene mutation associated with recurrent encephalopathy, intracranial calcification, and microcephaly: case report, long-term follow-up, and literature review.

Clinical dysmorphology
2026

Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency.

Movement disorders : official journal of the Movement Disorder Society
2025

Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

American journal of human genetics
2025

Biallelic NDUFA9 variants cause a progressive neurodevelopmental disorder with prominent dystonia and mitochondrial complex I deficiency.

Brain communications
2025

Hereditary Spastic Paraplegy Associated with the AP4S1 Gene: A Case Series Highlighting Diagnostic Pitfalls and Phenotypic Variability.

Molecular syndromology
2025

EIPR1 variants cause a neurodevelopmental disorder with endolysosomal and dense core vesicle defects.

Brain : a journal of neurology
2025

Reverse Shapiro Syndrome Presenting as Fever of Unknown Origin: A Case Report and Review of the Literature.

Cureus
2025

Kohlschütter-Tönz Syndrome: A Rare Clinical Entity with Amelogenesis Imperfecta in Two Siblings, Dental Management and Scoping Review.

Turkish archives of pediatrics
2025

Child Neurology: Clinical and Imaging Findings in a Child With DHX37 Gene Variant: A Ribosomopathy Masquerading as Cerebral Palsy.

Neurology
2025

A Case of Infantile Epileptic Spasms Syndrome with the SPTBN1 Mutation and Review of βII-Spectrin Variants.

Genes
2025

Post-acute Corticospinal and Spinal Tractopathy after Coronavirus Disease 2019: A Novel Post-infectious Neurological Syndrome?

Internal medicine (Tokyo, Japan)
2025

Clinical and genetic analysis of ERCC8-Related cockayne syndrome: hepatic dysfunction as a biomarker, anhidrosis as a rare feature, and rehabilitation outcomes for ankle contractures.

Frontiers in genetics
2025

Uncommon Allies: Van der Knaap Syndrome and Focal Segmental Glomerulosclerosis.

The Journal of the Association of Physicians of India
2025

Expanding the Epidemiological and Phenotypic Spectrum of MEGDEL Syndrome: The First Case Report From Egypt.

Clinical medicine insights. Pediatrics
2025

Genetic Deletion of Sarm1 in Mouse Models of Three Neurological Diseases.

Journal of the peripheral nervous system : JPNS
2025

BLOC1S1 variants cause lysosomal and autophagic defects resulting in a hypomyelinating leukodystrophy with epileptic encephalopathy.

medRxiv : the preprint server for health sciences
2025

Case report of paroxysmal dystonia in a child with KBG syndrome: Expansion of the phenotype and utility of whole exome sequencing.

Medicine
2025

Case Report: Heterozygous ADAR c.3019G>A pathogenic variant associated with variable neurological symptoms and incomplete penetrance in a four-generational family.

Frontiers in immunology
2025

Maternal uniparental isodisomy in a patient with autosomal recessive spastic paraplegia type 20.

Gene
2026

Identifying the Fourth Patient With Spastic Paraplegia 90, Extending the Phenotype Spectrum.

Clinical genetics
2025

Subacute Combined Degeneration Presenting With Prominent Autonomic Symptoms 12 Years After Total Gastrectomy: A Case Report.

Cureus
2025

A Report of a Child with SEC31A-Related Neurodevelopmental Disorder.

International journal of molecular sciences
2025

A Novel TAF1C Missense Variant Causes Neurodevelopmental Regression via Disrupted Nucleolar Localization and Nucleoplasmic Aggregation.

Clinical genetics
2025

Expanding the spectrum of ATP8A2 mutations: a new splicing variant and systematic review of CAMRQ4 syndrome.

Molecular biology reports
2025

New Phenotypes Associated With Pathogenic RNASEH2B and SAMHD1 Variants.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2025

Expanding the Allelic and Clinical Heterogeneity of Movement Disorders Linked to Defects of Mitochondrial Adenosine Triphosphate Synthase.

Movement disorders : official journal of the Movement Disorder Society
2025

The Rare Syndrome Aicardi-Goutières 4: A Case Report and Literature Review.

Developmental neurobiology
2025

Arginase 1 deficiency: a treatable form of spastic paraplegia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Heterozygous deletion of 10q24.31-q24.33- a new syndrome associated with multiple congenital anomalies: case report and literature review.

Neurological research and practice
2025

Delayed Diagnosis of Aicardi-Goutières Syndrome in a 10-Year-Old Female Child With TREX1 Mutation: A Case Report.

Cureus
2025

A Case Report of a Child With Rare Phosphatidylinositol Glycan Anchor Biosynthesis Class N (PIGN) Gene Mutation With Hypotonia, Epilepsy, and Global Developmental Delay.

Cureus
2025

De Novo Deletion in the 12q24.23q24.31 Chromosomal Region Causing a Neurodevelopmental Syndrome in a Female Saudi Patient: A Case Report.

Cureus
2025

[Combined oxidative phosphorylation deficiency type 7 caused by C12orf65 gene mutations: a case report and literature review].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2025

Phenotypic variability in progressive encephalopathy with brain atrophy and thin corpus callosum: insights from two families.

Neurogenetics
2024

Whole Exome Sequencing Facilitates Early Diagnosis of Lesch-Nyhan Syndrome: A Case Series.

Diagnostics (Basel, Switzerland)
2024

[A case of rare hereditary Siddiqi syndrome with novel neuropsychiatric signs].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2025

CHD3-related Snijders Blok-Campeau syndrome with Spastic Paraplegia, Ataxia, and Situs Inversus.

European journal of medical genetics
2025

Galloway-mowat syndrome 3 (GAMOS3): a novel disease-causing variant in OSGEP gene and expansion of the clinical spectrum.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

The phenotypic spectrum of PTCD3 deficiency.

JIMD reports
2024

Restoring Function in Pediatric Neurodegeneration: The Impact of Radio Electric Asymmetric Conveyor Neuroregenerative Treatment in a Child With Canavan Syndrome.

Cureus
2024

Cervical myelopathy mistaken for complex regional pain syndrome: A case report.

Medicine
2024

Atlantoaxial Instability due to Os Odontoideum in a Child with Christianson Syndrome.

Molecular syndromology
2024

Systemic complications of Aicardi Goutières syndrome using real-world data.

Molecular genetics and metabolism
2024

Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia.

Journal of clinical immunology
2025

Biallelic PTPMT1 variants disrupt cardiolipin metabolism and lead to a neurodevelopmental syndrome.

Brain : a journal of neurology
2024

Combined generalized and focal epilepsy with reflex features in Adaptor protein complex 4-associated hereditary spastic paraplegias: A cohort observational study.

Seizure
2024

Spectrum of Leukodystrophy and Genetic Leukoencephalopathy in Indian Population Diagnosed by Clinical Exome Sequencing and Clinical Utility.

Neurology. Genetics
2024

A case report of spastic diplegic cerebral palsy in a late preterm child with hypoplastic left heart syndrome.

Translational pediatrics
2024

Many Faces of Diencephalic-Mesencephalic Junction Dysplasia Syndrome with GSX2 and PCDH12 Variants.

Molecular syndromology
2024

A Case of Spastic Quadriplegia Remaining after Multiple Traumatic Injuries Complicated by Sepsis and Reversible Posterior Leukoencephalopathy Syndrome, as well as Delayed Multifocal Microbleeds.

Journal of emergencies, trauma, and shock
2024

A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of ATP8A2-related disorders caused by missense changes.

Neurogenetics
2024

Refining the phenotype of SINO syndrome: A comprehensive cohort report of 14 novel cases.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

Phenotypic variability related to dominant UCHL1 mutations: about three families with optic atrophy and ataxia.

Journal of neurology
2024

A Clinical Neurological Approach to the Child With Adenosine Deaminase Deficiency.

Pediatric neurology
2024

A Classic Cornelia De Lange Syndrome Type 5 (CdLS5) With a De Novo Missense Variation of p.Gly210Arg in the HDAC8 Gene With a Novel Phenotype of Generalized Dystonia.

Cureus
2024

Autosomal Recessive Spastic Paraplegia and Psychomotor Retardation With or Without Seizures: A Case Report From Saudi Arabia.

Cureus
2024

Expanding the phenotype of Harel-Yoon syndrome: A case report suggesting a genotype/phenotype correlation.

American journal of medical genetics. Part A
2024

[Clinical and genetic analysis of a child with West syndrome due to a de novo variant of NEXMIF gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

A Missense Variant in HACE1 Is Associated with Intellectual Disability, Epilepsy, Spasticity, and Psychomotor Impairment in a Pakistani Kindred.

Genes
2024

An Ultra-Rare Mixed Phenotype with Combined AP-4 and ERF Mutations: The First Report in a Pediatric Patient and a Literature Review.

Genes
2024

Recognition, Description, and Variability of Spasticity in Individuals With Multiple Sclerosis and Potential Barriers to Clinician-Patient Dialogue: Results From SEEN-MSS, a Large-Scale, Self-Reported Survey.

International journal of MS care
2024

CHD8-related disorders redefined: an expanding spectrum of dystonic phenotypes.

Journal of neurology
2024

Nucleotide metabolism, leukodystrophies, and CNS pathology.

Journal of inherited metabolic disease
2024

A treatable inborn error of metabolism presenting in the sixth decade.

BMJ case reports
2023

Case report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1/JAK2 inhibition.

Frontiers in immunology
2024

Delayed Diagnosis of Perrault Syndrome: A Rare Genetic Disorder.

Case reports in medicine
2024

Novel loss-of-function variants expand ABCC9-related intellectual disability and myopathy syndrome.

Brain : a journal of neurology
2023

Postural control deficits due to bilateral pyramidal tract lesions exemplified by hereditary spastic paraplegia (HSP) originate from increased feedback time delay and reduced long-term error corrections.

Frontiers in human neuroscience
2024

Novel Homozygous Variants of SLC13A5 Expand the Functional Heterogeneity of a Homogeneous Syndrome of Early Infantile Epileptic Encephalopathy.

Pediatric neurology
2023

De Sanctis-Cacchione Syndrome with Subdural Effusion: A Rare Case from India with Review of Literature.

Indian journal of dermatology
2024

GRM7-related disorder: five additional patients from three independent families and review of the literature.

European journal of medical genetics
2024

Bi-allelic ACBD6 variants lead to a neurodevelopmental syndrome with progressive and complex movement disorders.

Brain : a journal of neurology
2023

RAB1A haploinsufficiency phenocopies the 2p14-p15 microdeletion and is associated with impaired neuronal differentiation.

American journal of human genetics
2023

Methyl-CpG-Binding protein 2 duplication syndrome in a Chinese patient: A case report and review of the literature.

World journal of clinical cases
2024

Identification of novel homozygous variants in FOXE3 and AP4M1 underlying congenital syndromic anophthalmia and microphthalmia.

The journal of gene medicine
2023

A Young Boy with 21q21.1 Microdeletion Showing Speech Delay, Spastic Diplegia, and MRI Abnormalities: Original Case Report.

Global medical genetics
2023

Bilateral globus pallidus interna deep brain stimulation in the treatment of mixed cerebral palsy in ataxia with dyskinesia: a case report.

Frontiers in neurology
2023

Frontal lobe motor syndromes.

Handbook of clinical neurology
2023

TANGO2 Deficiency Disorder: Two Cases of Developmental Delay Preceding Metabolic Crisis.

Pediatric neurology
2023

The clinical aspects of septo-optic dysplasia: A narrative review with illustrative case report.

International journal of surgery case reports
2023

Biallelic MED27 variants lead to variable ponto-cerebello-lental degeneration with movement disorders.

Brain : a journal of neurology
2023

Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.

Cureus
2023

Congenital heart defects in CTNNB1 syndrome: Raising clinical awareness.

Clinical genetics
2023

Mutant SPART causes defects in mitochondrial protein import and bioenergetics reversed by Coenzyme Q.

Open biology
2023

Juvenile Dermatomyositis and Infantile Cerebral Palsy: Aicardi-Gouteres Syndrome, Type 5, with a Novel Mutation in SAMHD1-A Case Report.

Biomedicines
2024

Epileptic encephalopathy and amelogenesis imperfecta: What about KohlschüttereTönz syndrome? Case report and literature review.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2023

Case report: Mohr-Tranebjaerg syndrome: hearing impairment as the onset of an insidious disorder with high recurrence risk.

Frontiers in neurology
2023

Arginase deficiency-An unheralded cause of developmental epileptic encephalopathy.

Epileptic disorders : international epilepsy journal with videotape
2023

Dominant-negative variant in SLC1A4 causes an autosomal dominant epilepsy syndrome.

Annals of clinical and translational neurology
2023

Expanding the genetic spectrum of ALKU syndrome: Compound heterozygosity for two deleterious variants in SMG8 gene.

American journal of medical genetics. Part A
2023

Early versus late injections of Botulinumtoxin type A in post-stroke spastic movement disorder: A literature review.

Toxicon : official journal of the International Society on Toxinology
2023

Aicardi-Goutières syndrome type 7 in a Chinese child: A case report.

World journal of clinical cases
2023

Clinical and functional heterogeneity associated with the disruption of retinoic acid receptor beta.

Genetics in medicine : official journal of the American College of Medical Genetics
2023

Cation leak through the ATP1A3 pump causes spasticity and intellectual disability.

Brain : a journal of neurology
2023

Neurointerface with oscillator motifs for inhibitory effect over antagonist muscles.

Frontiers in neuroscience
2023

Quantitative measures of motor development in Angelman syndrome.

American journal of medical genetics. Part A
2023

Spondyloenchondrodysplasia in five new patients: identification of three novel ACP5 variants with variable neurological presentations.

Molecular genetics and genomics : MGG
2023

MECP2 duplication syndrome initially misdiagnosed as cerebral palsy: a case report.

The Journal of international medical research
2023

Sjögren-Larsson Syndrome: A Rare Presentation With Developmental Delay.

Cureus
2023

YIF1B-related Kaya-Barakat-Masson Syndrome: Report of a new patient and literature review.

European journal of medical genetics
2022

Phenotypic Pleiotropy in Arginase Deficiency: A Single Center Cohort.

Annals of Indian Academy of Neurology
2023

Novel, homozygous RAB3GAP1 c.2606 + 1G>A, p.Glu830ValfsTer9 variant and chromosome 3q29 duplication in a Turkish individual with Warburg micro syndrome.

Clinical dysmorphology
2023

Harel Yoon syndrome: a novel mutation in ATAD3A gene and expansion of the clinical spectrum.

Ophthalmic genetics
2023

Moyamoya syndrome secondary to mitochondrial disease in a patient with partial trisomy 13q14 and 13q31: A novel case report and literature review.

Heliyon
2023

TELO2-related syndrome (You-Hoover-Fong syndrome): Description of 14 new affected individuals and review of the literature.

American journal of medical genetics. Part A
2022

Detailed genetic and clinical analysis of a novel de novo variant in HPRT1: Case report of a female patient from Saudi Arabia with Lesch-Nyhan syndrome.

Frontiers in genetics
2023

The clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders.

Brain : a journal of neurology
2023

Early arteriopathy in Aicardi-Goutières syndrome 5. Case report and review of literature.

The neuroradiology journal
2023

Acral collodion membrane associated with ichthyosis due to a heterozygous pathogenic variant of ELOVL4 gene.

Pediatric dermatology
2022

Pre- and Postnatal Characterization of Autosomal Recessive KIDINS220-Associated Ventriculomegaly.

Molecular syndromology
2022

Would Zika virus Infection in Pregnancy Be a Sentence of Poor Neurological Prognosis for Exposed Children? Neurodevelopmental Outcomes in a Cohort from Brazilian Amazon.

Viruses
2022

Previously Undescribed Gross HACE1 Deletions as a Cause of Autosomal Recessive Spastic Paraplegia.

Genes
2022

Blended Phenotype of Prader-Willi Syndrome and HSP-SPG11 Caused by Maternal Uniparental Isodisomy.

Neurology. Genetics
2022

Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay due to Novel Mutations in the SACS Gene.

Journal of investigative medicine high impact case reports
2022

Startle Disease: An Overlooked Symptom of CTNNB1-Related Neurodevelopmental Disorder With Spastic Diplegia and Visual Defects.

Neurology. Genetics
2022

TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletions.

American journal of human genetics
2022

Molecular Genetics of GLUT1DS Italian Pediatric Cohort: 10 Novel Disease-Related Variants and Structural Analysis.

International journal of molecular sciences
2022

Bardet-Biedl Syndrome: A Rare Case From Ophthalmology Perspective.

Cureus
2022

Kjellin's syndrome: Spastic paraplegia and multifocal pattern dystrophy simulating fundus flavimaculatus.

Archivos de la Sociedad Espanola de Oftalmologia
2022

Phenotypic continuum of NFU1-related disorders.

Annals of clinical and translational neurology
2022

Milder presentation of autosomal dominant fatty acyl CoA reductase 1-related syndrome: Report of the first Middle Eastern patient and review of the literature.

Clinical case reports
2022

An association study of IL2RA polymorphisms with cerebral palsy in a Chinese population.

BMC medical genomics
2022

Genetic and clinical characteristics of 24 mainland Chinese patients with CTNNB1 loss-of-function variants.

Molecular genetics &amp; genomic medicine
2022

Early-Onset and Severe Complex Hereditary Spastic Paraplegia Caused by De Novo Variants in SPAST.

Movement disorders : official journal of the Movement Disorder Society
2022

Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement.

American journal of human genetics
2022

TRIT1 defect leads to a recognizable phenotype of myoclonic epilepsy, speech delay, strabismus, progressive spasticity, and normal lactate levels.

Journal of inherited metabolic disease
2022

Alternating hemiplegia of childhood: a distinct clinical entity and ATP1A3-related disorders: A narrative review.

Medicine
2022

PSMC1 variant causes a novel neurological syndrome.

Clinical genetics
2022

Novel EPG5 Mutation Associated with Vici Syndrome Gene.

Case reports in genetics
2022

Bi-allelic loss-of-function variants in PPFIBP1 cause a neurodevelopmental disorder with microcephaly, epilepsy, and periventricular calcifications.

American journal of human genetics
2022

A Dorsal Epidural Herniated Disc Fragment Initially Presenting as Guillain-Barré Syndrome.

Cureus
2022

A homozygous Y443C variant in the RNPC3 is associated with severe syndromic congenital hypopituitarism and diffuse brain atrophy.

American journal of medical genetics. Part A
2022

Mutations in TAF8 cause a neurodegenerative disorder.

Brain : a journal of neurology
2022

One Molecule for Mental Nourishment and More: Glucose Transporter Type 1-Biology and Deficiency Syndrome.

Biomedicines
2022

Adult-Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERDND ): Time to Move Beyond the Skin.

Movement disorders : official journal of the Movement Disorder Society
2022

NDUFAF6-Related Leigh Syndrome Caused by Rare Pathogenic Variants: A Case Report and the Focused Review of Literature.

Frontiers in pediatrics
2022

Neurological phenomenology of the IRF2BPL mutation syndrome: Analysis of a new case and systematic review of the literature.

Seizure
2022

PNPLA6/NTE, an Evolutionary Conserved Phospholipase Linked to a Group of Complex Human Diseases.

Metabolites
2022

El-Hattab-Alkuraya syndrome caused by biallelic WDR45B pathogenic variants: Further delineation of the phenotype and genotype.

Clinical genetics
2022

Autosomal Recessive Cerebellar Atrophy and Spastic Ataxia in Patients With Pathogenic Biallelic Variants in GEMIN5.

Frontiers in cell and developmental biology
2022

Gait as a quantitative translational outcome measure in Angelman syndrome.

Autism research : official journal of the International Society for Autism Research
2022

PRUNE1 c.933G>A synonymous variant induces exon 7 skipping, disrupts the DHHA2 domain, and leads to an atypical NMIHBA syndrome presentation: Case report and review of the literature.

American journal of medical genetics. Part A
2022

Molybdenum cofactor deficiency: A natural history.

Journal of inherited metabolic disease
2022

Possible EIF2AK2-Associated Stress-Related Neurological Decompensation with Combined Dystonia and Striatal Lesions.

Movement disorders clinical practice
2022

Bi-allelic variants in neuronal cell adhesion molecule cause a neurodevelopmental disorder characterized by developmental delay, hypotonia, neuropathy/spasticity.

American journal of human genetics
2022

Rhomboencephalosynapsis: Review of the Literature.

World neurosurgery
2022

Hemorrhagic shock and encephalopathy syndrome in a patient with a de novo heterozygous variant in KIF1A.

Brain &amp; development
2021

[Clinical phenotype and genetic analysis of MECP2 duplication syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2022

Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity.

Brain : a journal of neurology
2022

Congenital Eyelid Imbrication and Floppy Eyelid Syndrome in a Patient With Cat Eye Syndrome.

Ophthalmic plastic and reconstructive surgery
2021

Megaloblastic wobbliness: A reversible neurological condition.

Clinical nutrition ESPEN
2022

A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies.

American journal of medical genetics. Part A
2021

Leigh syndrome-like MRI changes in a patient with biallelic HPDL variants treated with ketogenic diet.

Molecular genetics and metabolism reports
2021

Identification of a large homozygous SPG21 deletion in a Chinese patient with Mast syndrome.

CNS neuroscience &amp; therapeutics
2021

Electroclinical Features in MECP2 Duplication Syndrome: Pediatric Case Series.

Journal of child neurology
2021

Identification of two novel homozygous mutations in ERCC8 gene in two unrelated consanguineous families with Cockayne syndrome from Iran.

Clinica chimica acta; international journal of clinical chemistry
2021

Biallelic PI4KA variants cause a novel neurodevelopmental syndrome with hypomyelinating leukodystrophy.

Brain : a journal of neurology
2021

Megalencephaly Polymicrogyria Polydactyly Hydrocephalus (MPPH): A Case Report and Review of Literature.

Cureus
2021

Re-analysis of whole-exome sequencing data reveals a novel splicing variant in the SLC2A1 in a patient with GLUT1 Deficiency Syndrome 1 accompanied by hemangioma: a case report.

BMC medical genomics
2021

Incidental Finding of MEGDEL Syndrome Based on Neuroimaging: Case Report.

Case reports in neurology
2022

Delineating the genotypic and phenotypic spectrum of HECW2-related neurodevelopmental disorders.

Journal of medical genetics
2021

Diseases caused by mutations in the Na+/K+ pump α1 gene ATP1A1.

American journal of physiology. Cell physiology
2021

Management of delayed Sprengel malformation with intracanalar compressive omovertebral bone in a developing country's neurosurgery unit.

BMJ case reports
2021

Aicardi syndrome in a 7-month-old girl with tonic seizures and skeletal defects: A case report.

Annals of medicine and surgery (2012)
2021

The Novel KIF1A Missense Variant (R169T) Strongly Reduces Microtubule Stimulated ATPase Activity and Is Associated With NESCAV Syndrome.

Frontiers in neuroscience
2021

Novel compound heterozygous STN1 variants are associated with Coats Plus syndrome.

Molecular genetics &amp; genomic medicine
2021

NGS-Based Diagnosis of Treatable Neurogenetic Disorders in Adults: Opportunities and Challenges.

Genes
2021

Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia.

Brain : a journal of neurology
2021

Novel manifestations of Warburg micro syndrome type 1 caused by a new splicing variant of RAB3GAP1: a case report.

BMC neurology
2021

Clinical, neuroimaging, and molecular spectrum of TECPR2-associated hereditary sensory and autonomic neuropathy with intellectual disability.

Human mutation
2021

Symptom Prevalence and Genotype-Phenotype Correlations in Patients With TANGO2-Related Metabolic Encephalopathy and Arrhythmias (TRMEA).

Pediatric neurology
2021

Phelan McDermid Syndrome: Multiple Sclerosis as a Rare but Treatable Cause for Regression-A Case Report.

International journal of molecular sciences
2021

Two Italian Patients with ELOVL4-Related Neuro-Ichthyosis:  Expanding the Genotypic and Phenotypic Spectrum and Ultrastructural Characterization.

Genes
2021

Blended Phenotype of Silver-Russell Syndrome and SPG50 Caused by Maternal Isodisomy of Chromosome 7.

Neurology. Genetics
2021

EIF2AK2-related Neurodevelopmental Disorder With Leukoencephalopathy, Developmental Delay, and Episodic Neurologic Regression Mimics Pelizaeus-Merzbacher Disease.

Neurology. Genetics
2021

Expanding the Clinical and Mutational Spectrum of the PLP1-Related Hypomyelination of Early Myelinated Structures (HEMS).

Brain sciences
2021

MED27 Variants Cause Developmental Delay, Dystonia, and Cerebellar Hypoplasia.

Annals of neurology
2021

Complications and Sequelae in Patients With Congenital Microcephaly Associated With Zika Virus Infection: Two-Year Follow-Up.

Journal of child neurology
2021

Successful liver transplantation in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: Case report.

Pediatric transplantation
2021

Milder presentation of TELO2-related syndrome in two sisters homozygous for the p.Arg609His pathogenic variant.

European journal of medical genetics
2021

A Case of Miyazaki Syndrome Caused by Arachnoid Cyst-Peritoneal Shunt.

World neurosurgery
2021

Defining the Expanding Clinical Spectrum of Pediatric-Onset Stiff Person Syndrome.

Pediatric neurology
2020

Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature.

Medicine
2020

A de novo CTNNB1 Novel Splice Variant in an Adult Female with Severe Intellectual Disability.

International medical case reports journal
2022

Charcot-Marie-Tooth disease type 4J with spastic quadriplegia, epilepsy and global developmental delay: a tale of three siblings.

The International journal of neuroscience

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de paraparesia espástica-cataratas-perturbação da linguagem.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de paraparesia espástica-cataratas-perturbação da linguagem

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p.Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome).
    Clinical genetics· 2026· PMID 41858232mais citado
  2. CTNNB1-related disorders: clinical and radiological contributions from a French cohort.
    Frontiers in neurology· 2026· PMID 41789168mais citado
  3. Systematic analysis of homozygous autosomal copy number losses in exomes improves diagnostic yield and uncovers ultra-rare recessive disorders.
    medRxiv : the preprint server for health sciences· 2026· PMID 41646768mais citado
  4. Expanding the neurological spectrum of HTLV-1 beyond HAM/TSP: a contemporary perspective.
    Lancet regional health. Americas· 2026· PMID 41551295mais citado
  5. Identifying the Fourth Patient With Spastic Paraplegia 90, Extending the Phenotype Spectrum.
    Clinical genetics· 2026· PMID 40533086mais citado
  6. Mast cell mediators in hereditary angioedema.
    Orphanet J Rare Dis· 2026· PMID 41832580recente
  7. Prenatal Molecular Diagnosis of COL2A1-Associated Stickler Syndrome: Genotype-Phenotype Correlation in a Resource-Limited Healthcare Setting.
    Int J Mol Sci· 2026· PMID 41828453recente
  8. Platelet gene signatures detecting pulmonary artery stenosis in patients with pulmonary hypertension.
    Orphanet J Rare Dis· 2026· PMID 41827036recente
  9. The global impact of imiglucerase therapy in children with Gaucher disease types 1 and 3: a real-world analysis from the International Collaborative Gaucher Group Gaucher Registry.
    Orphanet J Rare Dis· 2026· PMID 41821052recente
  10. Monogenic lupus with SLC7A7 mutations: a retrospective study from a Chinese center.
    Orphanet J Rare Dis· 2026· PMID 41821046recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:615938(Orphanet)
  2. OMIM OMIM:619338(OMIM)
  3. MONDO:0036212(MONDO)
  4. GARD:18033(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q122937759(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome de paraparesia espástica-cataratas-perturbação da linguagem

ORPHA:615938 · MONDO:0036212
CID-10
E71.3 · Distúrbios do metabolismo de ácidos graxos
MedGen
UMLS
C5543440
Repurposing
2 candidatos
luteinantioxidant
pirenoxineAGE inhibitor
Wikidata
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades